Burkly Linda
SEC CIK 1985604 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EDIT | Editas Medicine, Inc. | EVP, CSO | 61.7K | — | $105.5K | 12 | 2023-07-24 | 2026-09-03 |
Most active insiders at EDIT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | O'Neill Gilmore Neil | CEO, Dir | — | $80.0K |
| 2 | Burkly Linda | EVP, CSO | — | $20.3K |
| 3 | Parison Amy | SVP, CFO | — | $6,327 |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-04 16:27 | 2026-09-03 | EDIT | Editas Medicine, Inc. | Burkly Linda | EVP, CSO | S - Sale | $3.04 | -709 | 61.7K | -1% | -$2,153 |
| T | 2026-07-29 16:51 | 2026-07-28 | EDIT | Editas Medicine, Inc. | Burkly Linda | EVP, CSO | S - Sale | $2.67 | -4,928 | 62.4K | -7% | -$13.2K |
| T | 2026-06-05 16:32 | 2026-06-03 | EDIT | Editas Medicine, Inc. | Burkly Linda | EVP, CSO | S - Sale | $2.70 | -731 | 67.3K | -1% | -$1,975 |
| 2026-03-04 | 2026-03-03 | EDIT | Editas Medicine, Inc. | Burkly Linda | EVP, CSO | S - Sale | $2.02 | -749 | 68.0K | -1% | -$1,513 | |
| 2025-12-04 | 2025-12-03 | EDIT | Editas Medicine, Inc. | Burkly Linda | EVP, CSO | S - Sale | $2.15 | -713 | 68.8K | -1% | -$1,533 | |
| 2025-09-04 | 2025-09-03 | EDIT | Editas Medicine, Inc. | Burkly Linda | EVP, CSO | S - Sale | $2.60 | -710 | 69.5K | -1% | -$1,846 | |
| 2025-08-04 | 2025-07-31 | EDIT | Editas Medicine, Inc. | Burkly Linda | EVP, CSO | S - Sale | $2.49 | -5,121 | 64.4K | -7% | -$12.8K | |
| 2025-06-04 | 2025-06-03 | EDIT | Editas Medicine, Inc. | Burkly Linda | EVP, CSO | S - Sale | $1.72 | -726 | 69.5K | -1% | -$1,249 | |
| 2025-03-05 | 2025-03-04 | EDIT | Editas Medicine, Inc. | Burkly Linda | EVP, CSO | S - Sale | $1.71 | -2,891 | 70.2K | -4% | -$4,944 | |
| 2024-07-26 | 2024-07-25 | EDIT | Editas Medicine, Inc. | Burkly Linda | EVP, CSO | S - Sale | $5.42 | -11.9K | 73.1K | -14% | -$64.4K | |
| DM | 2024-03-05 | 2024-03-02 | EDIT | Editas Medicine, Inc. | Burkly Linda | EVP, CSO | A - Grant | $0.00 | +39.9K | 85.0K | +88% | $0 |
| D | 2023-07-25 | 2023-07-24 | EDIT | Editas Medicine, Inc. | Burkly Linda | EVP, CSO | A - Grant | $0.00 | +45.2K | 45.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations